Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Delaware Growth and Income A FGINX
- NAV / 1-Day Return 14.82 / −0.40 %
- Total Assets 1.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.020%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 2.05%
- Turnover 26%
USD | NAV as of Apr 17, 2024 | 1-Day Return as of Apr 17, 2024, 11:53 PM GMT+0
Morningstar’s Analysis FGINX
Will FGINX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 34.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Exxon Mobil Corp | 4.74 | 61.3 Mil | Energy |
Merck & Co Inc | 4.38 | 56.6 Mil | Healthcare |
Cisco Systems Inc | 3.59 | 46.4 Mil | Technology |
The Cigna Group | 3.56 | 46.1 Mil | Healthcare |
Lowe's Companies Inc | 3.33 | 43.1 Mil | Consumer Cyclical |
Gilead Sciences Inc | 3.11 | 40.2 Mil | Healthcare |
CVS Health Corp | 3.03 | 39.2 Mil | Healthcare |
Bristol-Myers Squibb Co | 2.95 | 38.1 Mil | Healthcare |
Philip Morris International Inc | 2.93 | 37.9 Mil | Consumer Defensive |
Broadcom Inc | 2.81 | 36.3 Mil | Technology |